PCK1 and ALDH1A1 are identified as biomarkers for inherent drug resistance in hepatocellular carcinoma
{{output}}
Background: Hepatocellular carcinoma (HCC) is a major cause of cancer-related deaths worldwide, often diagnosed at advanced stages with limited treatment options. Despite advancements in systemic therapies, including the use of l... ...